Mamisan Pain Ointment Withdrawn Over Child Safety Concerns
Children’s safety is a primary concern with the recent recall of Mamisan Pain Relieving Topical Ointment. This decision comes after federal officials warned that the packaging could pose life-threatening risks to children if ingested.
Mamisan Pain Ointment Recall Details
Plantimex Distributors is recalling approximately 50,000 jars of this widely used product. The recall is due to the ointment’s lid failing to meet child-resistant safety standards as assessed by the Consumer Product Safety Commission (CPSC).
Safety Concerns and Instructions
The CPSC emphasizes that consumers should secure these jars away from children’s reach without delay. A free replacement lid is available from Plantimex for customers who have purchased this product.
- Contact Plantimex at 855-752-6869.
- Email: [email protected] (include “subject recall”).
Product Information
Mamisan ointment contains lidocaine, a numbing agent, which requires compliant packaging to ensure children’s safety. The jars are bright orange and feature a twist-off lid. Only jars marked with the UPC code 860006498115 are affected by this recall.
This product was sold nationwide at retailers such as Walmart and Target, as well as on Target.com, from April 2024 to October 2023.
Consumer Action Required
Immediately remove any affected jars from children’s access. After securing a replacement lid, consumers can resume using the product as directed. Your prompt action can help ensure the safety of children.
